Atuzaginstat

LONDON, United Kingdom, July 13, 2026 GSK has announced positive interim results from the registrational Phase II AZUR-1 clinical...

NOVATO, California, July 13, 2026 Lighthouse Pharmaceuticals has announced new clinical findings from its Phase 2/3 GAIN trial, demonstrating...